Esophageal cancer
Conditions
Interventions
Near-Infrared Fluorescence imaging group :Esophageal cancer surgery using indocyanine green-based near-infrared fluorescence technology
Historical control group:Conventional esophageal cancer surgery (no intraoperative use of indocyanine green-based near-infrared fluorescence technology)
Sponsors
Sun Yat-Sen University Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: ? Patients who underwent radical esophagectomy for esophageal cancer in the Department of Thoracic Medicine of Sun Yat-sen University Cancer Center from 2016 to 2023; ? Patients diagnosed with esophageal cancer in the middle and lower thoracic segments; ? Patients with esophageal cancer who have not undergone neoadjuvant therapy.
Exclusion criteria
Exclusion criteria: Exclusions were made for patients presenting with cervical and upper thoracic esophageal cancer, multi-originated esophageal cancer, individuals who underwent Sweet surgical procedures, as well as those with a history of neoadjuvant therapy including chemotherapy, radiotherapy, or chemoradiotherapy for current esophageal cancer. Further exclusions were patients with an iodide or ICG allergy, distant metastasis, and unresectable esophageal cancer, specifically in cases where the tumors involved the heart, large blood vessels, trachea, or vertebral body.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3-year disease-free survival (DFS);3-year overall survival (OS);Recurrence patterns; | — |
Countries
China
Contacts
Public ContactYi Hu
Sun Yat-Sen University Cancer Center
Outcome results
None listed